Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT00004103
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • cisplatin — DRUG
  • floxuridine — DRUG
  • irinotecan hydrochloride — DRUG
  • adjuvant therapy — PROCEDURE
  • conventional surgery — PROCEDURE
  • neoadjuvant therapy — PROCEDURE

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.

Key Dates

Start date
Jul 31, 1998
Status verified
Apr 2011
Primary completion
Mar 31, 2007
Completion
Jun 30, 2009

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Cancer Institute at New York University Medical CenterNew YorkNew York10016-

Find similar trials in New York, NY

By condition
Gastric cancer
By specialty
OncologyGI oncology
By research site
NYU Cancer Institute at New York University Medical Center· New York, NY

Related Studies